How Myriad’s myPlan Addresses the Risk of Recurrence in Lung Cancer

myriad genetics
  • FLASCO
  • October 20, 2016

Benjamin P. Levy, MD, assistant professor at the Icahn School of Medicine, medical director of the Thoracic Oncology Program, Mount Sinai Health Systems, and associate director of the Cancer Clinical Trials Office at Mount Sinai Hospital in New York, discusses how Myriad’s myPlan addresses the risk of recurrence in lung cancer.

© 2020 FLASCO | Premium Website Design by The HDG

FLASCO